AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 37 filers reported holding AIM IMMUNOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,359 | -32.1% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,891 | +55.8% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,064 | +37.9% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,673 | -38.8% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -33.3% | 11,777 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $9,000 | -25.0% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | +20.0% | 11,777 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $10,000 | -56.5% | 11,777 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $23,000 | -4.2% | 11,777 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -7.7% | 11,777 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $26,000 | 0.0% | 11,777 | -20.3% | 0.00% | -20.0% |
| Q4 2020 | $26,000 | -16.1% | 14,777 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $31,000 | +6.9% | 14,777 | +25.5% | 0.01% | 0.0% |
| Q2 2020 | $29,000 | -3.3% | 11,777 | 0.0% | 0.01% | -36.4% |
| Q1 2020 | $30,000 | – | 11,777 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |